ライフサイエンスコーパス: hyperactivity disorder

1 sorder, schizophrenia, and attention-deficit/hyperactivity disorder).

2 isorder, schizophrenia and attention deficit-hyperactivity disorder.

3 the exclusion of comorbid attention-deficit/hyperactivity disorder.

4 ce Test and diagnosis with attention-deficit/hyperactivity disorder.

5 chiatric disorders such as attention deficit hyperactivity disorder.

6 schizophrenia, autism, and attention deficit hyperactivity disorder.

7 ective in the treatment of attention-deficit/hyperactivity disorder.

8 iatric diseases, including attention deficit/hyperactivity disorder.

9 us findings in adults with attention-deficit/hyperactivity disorder.

10 of Alzheimer's disease and attention deficit hyperactivity disorder.

11 ion or substance abuse and attention-deficit/hyperactivity disorder.

12 rofile and a lower risk of attention deficit hyperactivity disorder.

13 ility to schizophrenia and attention deficit hyperactivity disorder.

14 , Alzheimer's disease, and attention deficit hyperactivity disorder.

15 ke inhibitor used to treat attention-deficit/hyperactivity disorder.

16 uding the calming ones, in attention deficit hyperactivity disorder.

17 natopic conditions such as attention deficit hyperactivity disorder.

18 ior studies in adults with attention-deficit/hyperactivity disorder.

19 same set of patients with attention deficit/hyperactivity disorder.

20 of oral methylphenidate in attention deficit/hyperactivity disorder.

21 ing obesity, addiction and attention deficit hyperactivity disorder.

22 nia, bipolar disorder, and attention-deficit/hyperactivity disorder.

23 s, particularly autism and attention-deficit hyperactivity disorder.

24 order, autism, anxiety and attention deficit/hyperactivity disorder.

25 tism spectrum disorder, or attention-deficit/hyperactivity disorder.

26 syndrome, autism, and attention deficit and hyperactivity disorder.

27 pathological gambling, and attention deficit hyperactivity disorder.

28 25 (4.8%) met criteria for attention-deficit/hyperactivity disorder.

29 or depressive disorder, or attention-deficit/hyperactivity disorder.

30 riability in patients with attention deficit hyperactivity disorder.

31 chiatric disorders such as attention-deficit hyperactivity disorder.

32 RR, 4.3; 95% CI, 2.3-8.2), attention-deficit/hyperactivity disorder (189 cases [5.3%] vs 180 controls

33 y also had higher rates of attention deficit hyperactivity disorder (30.7% compared with 18.1%), disr

34 r (94.2 [1.69]; P = .004), attention-deficit/hyperactivity disorder (96.3 [0.91]; P = .002), oppositi

35 in the pharmacotherapy of attention deficit hyperactivity disorder, a common condition in which circ

36 Attention-deficit/hyperactivity disorder according to DSM-IV diagnostic cr

37 o tested 21 children with attention deficit (hyperactivity) disorder [AD(H)D].

38 pectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) - prevalent and often high

39 Attention-deficit/hyperactivity disorder (ADHD) affects 39 million people

40 that many individuals with attention deficit hyperactivity disorder (ADHD) also have difficulties wit

41 Attention-deficit/hyperactivity disorder (ADHD) and anxiety-related disord

42 PBDEs and intelligence or Attention Deficit/Hyperactivity Disorder (ADHD) and attention-related beha

43 Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum Disord

44 opmental disorders such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disord

45 d between extraversion and attention-deficit-hyperactivity disorder (ADHD) and between openness and s

46 Attention-deficit/hyperactivity disorder (ADHD) and bipolar disorder (BPD)

47 asted with trajectories in attention-deficit/hyperactivity disorder (ADHD) and childhood-onset schizo

48 as well as treatments for attention deficit hyperactivity disorder (ADHD) and depression.

49 observed in children with attention deficit/hyperactivity disorder (ADHD) and has been frequently li

50 been effective in treating attention-deficit/hyperactivity disorder (ADHD) and is currently the first

51 Patients with attention-deficit/hyperactivity disorder (ADHD) and obsessive-compulsive d

52 s used clinically to treat attention-deficit/hyperactivity disorder (ADHD) and off-label as a perform

53 iological underpinnings of attention-deficit/hyperactivity disorder (ADHD) and particularly those ass

54 m spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD) and schizophrenia (SCZ).

55 iatric disorders including attention deficit hyperactivity disorder (ADHD) and schizophrenia (SZ) hav

56 viously observed to impact attention deficit hyperactivity disorder (ADHD) and schizophrenia.

57 tric conditions, including attention deficit hyperactivity disorder (ADHD) and substance use disorder

58 n the relationship between attention-deficit hyperactivity disorder (ADHD) and younger relative age i

59 Patients with attention-deficit/hyperactivity disorder (ADHD) are at an increased risk o

60 Individuals with attention-deficit/hyperactivity disorder (ADHD) are at greater risk for ac

61 Cigarette smoking and attention-deficit/hyperactivity disorder (ADHD) are highly comorbid.

62 ated that individuals with attention-deficit/hyperactivity disorder (ADHD) are more likely to experie

63 rsistence and remission of attention-deficit/hyperactivity disorder (ADHD) are poorly understood.

64 Epilepsy and attention-deficit/hyperactivity disorder (ADHD) are strongly associated; h

65 Parkinsonism and attention deficit hyperactivity disorder (ADHD) are widespread brain disor

66 Attention-deficit/hyperactivity disorder (ADHD) can be viewed as the extre

67 adult outcome of childhood attention deficit hyperactivity disorder (ADHD) could guide novel interven

68 Children with ASD or attention-deficit hyperactivity disorder (ADHD) delivered in a large New E

69 Attention-deficit/hyperactivity disorder (ADHD) diagnosis is based on repo

70 mic activity is altered in attention-deficit/hyperactivity disorder (ADHD) during tasks requiring cog

71 Adults with attention-deficit/hyperactivity disorder (ADHD) exhibit slowed reaction ti

72 ectrum disorders (ASD) and attention-deficit/hyperactivity disorder (ADHD) frequently co-occur.

73 uestioned the stability of attention-deficit hyperactivity disorder (ADHD) from childhood to adulthoo

74 Attention-deficit/hyperactivity disorder (ADHD) has an uncertain etiology,

75 Attention-deficit/hyperactivity disorder (ADHD) has been associated with d

76 Attention deficit hyperactivity disorder (ADHD) has been increasingly reco

77 Attention-deficit/hyperactivity disorder (ADHD) has been often found to be

78 ldren and adolescents with attention-deficit/hyperactivity disorder (ADHD) have an increased risk of

79 Neuroimaging studies of attention-deficit/hyperactivity disorder (ADHD) have most commonly reporte

80 ng (fMRI) studies of adult attention-deficit/hyperactivity disorder (ADHD) have revealed various ADHD

81 oimaging investigations in attention-deficit/hyperactivity disorder (ADHD) have separately identified

82 ences were associated with attention-deficit/hyperactivity disorder (ADHD) in a recent multi-site, me

83 erion for the diagnosis of attention-deficit/hyperactivity disorder (ADHD) in adults, but recently th

84 arning disability (LD) and attention deficit/hyperactivity disorder (ADHD) in children 6-15 years of

85 medications used to treat attention-deficit/hyperactivity disorder (ADHD) increase sympathetic tone

86 Attention deficit hyperactivity disorder (ADHD) is a childhood-onset neuro

87 Attention deficit hyperactivity disorder (ADHD) is a common childhood beha

88 Attention-deficit hyperactivity disorder (ADHD) is a common childhood beha

89 Attention deficit hyperactivity disorder (ADHD) is a common mental disorde

90 Attention-deficit/hyperactivity disorder (ADHD) is a common, highly herita

91 Attention-deficit/hyperactivity disorder (ADHD) is a heritable neurodevelo

92 Importance: Attention-deficit/hyperactivity disorder (ADHD) is a heritable neurodevelo

93 Attention-deficit/hyperactivity disorder (ADHD) is a heritable, chronic, n

94 Attention-deficit/hyperactivity disorder (ADHD) is a highly heritable neur

95 Attention deficit hyperactivity disorder (ADHD) is a neurobehavioral disor

96 Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental di

97 Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental di

98 Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental di

99 Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental di

100 Attention-deficit hyperactivity disorder (ADHD) is a prevalent and highly

101 Attention-deficit/hyperactivity disorder (ADHD) is a prevalent development

102 Attention-deficit/hyperactivity disorder (ADHD) is among the most common p

103 Attention-deficit/hyperactivity disorder (ADHD) is associated with a broad

104 Attention-deficit/hyperactivity disorder (ADHD) is associated with high ra

105 Attention deficit hyperactivity disorder (ADHD) is associated with increas

106 Attention-deficit/hyperactivity disorder (ADHD) is associated with structu

107 Studies have shown that attention-deficit/hyperactivity disorder (ADHD) is associated with transpo

108 Attention-deficit/hyperactivity disorder (ADHD) is characterized by proble

109 Recognition that adult attention-deficit/hyperactivity disorder (ADHD) is common, seriously impai

110 Attention-deficit/hyperactivity disorder (ADHD) is conceptualized as a neu

111 Attention-deficit hyperactivity disorder (ADHD) is estimated to affect 8-1

112 us research indicates that attention-deficit/hyperactivity disorder (ADHD) is highly associated with

113 Although attention-deficit hyperactivity disorder (ADHD) is highly heritable, and l

114 Although attention deficit hyperactivity disorder (ADHD) is highly heritable, genom

115 Although attention-deficit/hyperactivity disorder (ADHD) is highly prevalent in ado

116 pectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) is increasingly appreciate

117 Attention-deficit/hyperactivity disorder (ADHD) is increasingly conceived

118 Attention-deficit/hyperactivity disorder (ADHD) is increasingly viewed as

119 Attention-deficit/hyperactivity disorder (ADHD) is now recognized to occur

120 Attention deficit and hyperactivity disorder (ADHD) is often assumed to be ass

121 Adult attention-deficit/hyperactivity disorder (ADHD) is prevalent but often unr

122 Attention-deficit/hyperactivity disorder (ADHD) is the most common childho

123 ldren and adolescents with attention deficit hyperactivity disorder (ADHD) is unclear.

124 e to a previously reported attention-deficit hyperactivity disorder (ADHD) linkage locus and an evide

125 and inattention related to attention deficit hyperactivity disorder (ADHD) may increase food intake a

126 Attention-deficit/hyperactivity disorder (ADHD) often persists into adoles

127 g adults without childhood attention deficit hyperactivity disorder (ADHD) often present to clinics s

128 o PFASs is associated with attention deficit/hyperactivity disorder (ADHD) or childhood autism in chi

129 Childhood attention-deficit/hyperactivity disorder (ADHD) persists into adulthood in

130 Attention-deficit/hyperactivity disorder (ADHD) research has long focused

131 Attention-deficit/hyperactivity disorder (ADHD) shows substantial heritabi

132 al-based classification of attention-deficit/hyperactivity disorder (ADHD) subtypes has thus far rema

133 Attention-deficit/hyperactivity disorder (ADHD) symptoms are most commonly

134 ted to traffic (ECAT), and attention deficit/hyperactivity disorder (ADHD) symptoms at 7 years of age

135 strength at rest predicted attention-deficit/hyperactivity disorder (ADHD) symptoms in an independent

136 nabis co-use, craving, and attention-deficit/hyperactivity disorder (ADHD) symptoms on startle measur

137 ation of VLF EEG power and Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms was examined.

138 d the effects of childhood attention deficit hyperactivity disorder (ADHD) symptoms, both inattention

139 ategorical ASD diagnosis); attention-deficit/hyperactivity disorder (ADHD) traits (4 versions of Conn

140 rder, major depression and attention deficit hyperactivity disorder (ADHD) using genomic data from 15

141 Attention deficit hyperactivity disorder (ADHD) was the most frequent diso

142 For many years, attention-deficit hyperactivity disorder (ADHD) was thought to be a childh

143 pulsive disorder (OCD) and attention-deficit/hyperactivity disorder (ADHD) were excluded, and 72.1% o

144 moking during pregnancy to attention-deficit/hyperactivity disorder (ADHD) without elucidating specif

145 brain disorders, including attention-deficit/hyperactivity disorder (ADHD), aggression, post-traumati

146 g intellectual disability, attention deficit/hyperactivity disorder (ADHD), and autism spectrum disor

147 , variable expressivity of attention deficit hyperactivity disorder (ADHD), and motor delay.

148 tem has been implicated in attention-deficit/hyperactivity disorder (ADHD), and nicotinic agonists im

149 genetic susceptibility of Attention-Deficit/Hyperactivity Disorder (ADHD), but without much success.

150 al disabilities, including attention-deficit hyperactivity disorder (ADHD), intellectual disability (

151 oride for the treatment of attention-deficit/hyperactivity disorder (ADHD), little is known about age

152 Attention-deficit hyperactivity disorder (ADHD), one of the most common ps

153 ms of depression, anxiety, attention/deficit hyperactivity disorder (ADHD), oppositional defiant diso

154 ted behavioral hallmark of attention-deficit/hyperactivity disorder (ADHD), strongly influences addic

155 used for the treatment of attention-deficit hyperactivity disorder (ADHD), suppress social play in r

156 stand the underpinnings of attention-deficit/hyperactivity disorder (ADHD), we targeted the relations

157 ition is a core deficit of attention deficit hyperactivity disorder (ADHD), which is a common childho

158 Here we focus on attention-deficit/hyperactivity disorder (ADHD), which is at least partly

159 s who share a diagnosis of attention-deficit hyperactivity disorder (ADHD), with other studies identi

160 t of stress on severity of attention deficit hyperactivity disorder (ADHD), with stronger effects of

161 ity among individuals with attention deficit hyperactivity disorder (ADHD), yet associations between

162 a use case of HaploReg for attention deficit hyperactivity disorder (ADHD)-associated SNPs with putat

163 nfancy are associated with attention deficit/hyperactivity disorder (ADHD)-related behaviors at 8 yea

164 s the literature regarding attention-deficit/hyperactivity disorder (ADHD)-related driving impairment

165 ulsive disorder (OCD), and attention deficit hyperactivity disorder (ADHD).

166 ychopathologies, including attention deficit hyperactivity disorder (ADHD).

167 iatric disorders including attention deficit hyperactivity disorder (ADHD).

168 predispose individuals to attention-deficit/hyperactivity disorder (ADHD).

169 pectrum disorder (ASD) and attention-deficit hyperactivity disorder (ADHD).

170 ellum has been reported in attention-deficit/hyperactivity disorder (ADHD).

171 atopic dermatitis (AD) and attention-deficit/hyperactivity disorder (ADHD).

172 r region of this gene with attention-deficit/hyperactivity disorder (ADHD).

173 used for the treatment of attention-deficit/hyperactivity disorder (ADHD).

174 ding schizophrenia and attention deficit and hyperactivity disorder (ADHD).

175 chiatric disorders such as attention deficit hyperactivity disorder (ADHD).

176 xternalising symptoms, and attention-deficit hyperactivity disorder (ADHD).

177 to the clinical course of attention deficit hyperactivity disorder (ADHD).

178 ive function impairment in attention deficit hyperactivity disorder (ADHD).

179 ttention problems, such as attention deficit/hyperactivity disorder (ADHD).

180 mportant endophenotype for attention deficit hyperactivity disorder (ADHD).

181 levated risk of developing attention-deficit/hyperactivity disorder (ADHD).

182 ive association of AE with attention-deficit hyperactivity disorder (ADHD).

183 st effective treatment for attention-deficit/hyperactivity disorder (ADHD).

184 tric conditions, including attention deficit hyperactivity disorder (ADHD).

185 pathogenesis of autism and attention-deficit/hyperactivity disorder (ADHD).

186 c categories for childhood attention-deficit/hyperactivity disorder (ADHD).

187 ifferentially impaired in attention-deficit/ hyperactivity disorder (ADHD).

188 te to the core symptoms of Attention Deficit/Hyperactivity Disorder (ADHD).

189 mproves cognition in adult attention-deficit/hyperactivity disorder (ADHD).

190 l features associated with attention-deficit/hyperactivity disorder (ADHD).

191 s have been identified for attention-deficit/hyperactivity disorder (ADHD).

192 often exhibit symptoms of attention-deficit/hyperactivity disorder (ADHD).

193 n children and adults with attention deficit hyperactivity disorder (ADHD).

194 on of which is a factor in attention-deficit/hyperactivity disorder (ADHD).

195 S), and characteristics of attention-deficit/hyperactivity disorder (ADHD).

196 and could be relevant for attention-deficit/hyperactivity disorder (ADHD).

197 mal model for the study of attention deficit hyperactivity disorder (ADHD).

198 o have been diagnosed with attention deficit hyperactivity disorder (ADHD); however, the action mecha

199 epeats have been linked to attention-deficit/hyperactivity disorder (ADHD); however, the underlying m

200 variant has been linked to attention-deficit/hyperactivity disorder (ADHD); however, the underlying m

201 ldren and adolescents with attention-deficit/hyperactivity disorder (ADHD)?

202 a Exchange (ABIDE) and the Attention-Deficit Hyperactivity Disorder (ADHD-200) databases.

203 opmental disorders (NDDs) (attention deficit hyperactivity disorder [ADHD], autism spectrum disorder

204 ely to have a diagnosis of attention-deficit/hyperactivity disorder (adjusted odds ratio = 4.0; 95% C

205 were clinically at risk of attention deficit hyperactivity disorders after Bonferroni correction for

206 essive daytime sleepiness, attention deficit hyperactivity disorder, Alzheimer disease, ethanol addic

207 ixteen adult patients with attention deficit/hyperactivity disorder and 16 matched healthy control su

208 tween the Pro33 allele and attention-deficit hyperactivity disorder and ASDs.

209 function is implicated in attention-deficit/hyperactivity disorder and autism spectrum disorder.

210 ng infantile parkinsonism, attention-deficit/hyperactivity disorder and autism spectrum disorder.

211 high impulsivity, such as attention-deficit/hyperactivity disorder and bipolar disorder.

212 ), behavioral disturbance (attention deficit hyperactivity disorder and conduct disorder), psychosis-

213 atric disorders, including attention-deficit hyperactivity disorder and drug addiction.

214 Some conditions, such as attention-deficit/hyperactivity disorder and inpatient well-newborn care,

215 avior disorders, such as attention-deficient/hyperactivity disorder and oppositional defiant disorder

216 armacologic treatments for attention-deficit/hyperactivity disorder and other conditions associated w

217 r excluding relatives with attention-deficit/hyperactivity disorder and probands with suicidal behavi

218 etiology and treatment of attention-deficit/hyperactivity disorder and related disorders.

219 mental disorders, such as attention deficit-hyperactivity disorder and schizophrenia.

220 schizophrenia, depression, attention-deficit hyperactivity disorder and substance abuse disorders.

221 listed in DSM-5, including attention-deficit/hyperactivity disorder and substance use disorder.

222 behavior in patients with attention-deficit/hyperactivity disorder and suggests that individuals wit

223 obtained for the level of attention-deficit/hyperactivity disorder and the influence of type of hear

224 ests that individuals with attention-deficit/hyperactivity disorder and their family members are impo

225 Attention-deficit/hyperactivity disorder and well-dental care (including d

226 mood dysregulation, and/or attention-deficit/hyperactivity disorders and 22 healthy youths.

227 patient well-newborn care, attention-deficit/hyperactivity disorder, and asthma among all conditions.

228 , including schizophrenia, attention deficit/hyperactivity disorder, and autism spectrum disorders.

229 e disorder and behaviours, attention deficit hyperactivity disorder, and autistic spectrum disorder.

230 traumatic stress disorder, attention-deficit/hyperactivity disorder, and conduct problems), and consi

231 seases, such as addiction, attention-deficit/hyperactivity disorder, and schizophrenia.

232 orders, such as addiction, attention-deficit/hyperactivity disorder, and schizophrenia.

233 sorders, including autism, attention-deficit/hyperactivity disorder, and schizophrenia.

234 athology, such as anxiety, attention deficit hyperactivity disorder, and substance use.

235 ia, autism, depression and attention deficit hyperactivity disorder, as well as ageing.

236 ric diagnosis of interest (attention-deficit/hyperactivity disorder, autism spectrum disorder, schizo

237 odevelopmental phenotypes (attention deficit hyperactivity disorder, autism spectrum disorder, seizur

238 rs in offspring, including attention deficit/hyperactivity disorder, autism, and schizophrenia.

239 between schizophrenia and attention deficit hyperactivity disorder/autism.

240 r clinical development for attention deficit hyperactivity disorder, binge eating disorder, cocaine a

241 moking with drug and AUDs, attention-deficit hyperactivity disorder, bipolar disorder and antisocial

242 diabetes, waist-hip ratio, attention deficit hyperactivity disorder, bipolar disorder, major depressi

243 d social behavior and that attention deficit hyperactivity disorder, bipolar disorder, schizophrenia,

244 approved for children with attention deficit hyperactivity disorder but not well studied in ASD.

245 xposed were diagnosed with attention-deficit/hyperactivity disorder by age 15 years.

246 gotic twins discordant for attention deficit hyperactivity disorder can elucidate mechanisms that con

247 but represented 55.9% when attention-deficit/hyperactivity disorder codes were excluded.

248 ty in patients with autism/attention deficit hyperactivity disorder, compared with respective control

249 ocial anxiety disorder and attention-deficit/hyperactivity disorder, complete mediation was found.

250 of why many children with attention deficit hyperactivity disorder do not outgrow the disorder by ad

251 tensive drugs, sleep aids, attention-deficit/hyperactivity disorder drugs, and antidepressant drugs)

252 of insomnia [sleep aids], attention-deficit/hyperactivity disorder drugs, antidepressant drugs, and

253 ilities, including autism, attention-deficit hyperactivity disorder, dyslexia, and other cognitive im

254 th preschool-aged onset of attention-deficit/hyperactivity disorder; early exposure to parental depre

255 schizophrenia, depression, attention-deficit/hyperactivity disorder, eating disorders, autism spectru

256 or depressive disorder and attention-deficit hyperactivity disorder from their controls but moderatel

257 of attention--symptoms of attention deficit hyperactivity disorder--from resting-state connectivity

258 The adult form of attention-deficit/hyperactivity disorder has a prevalence of up to 5% and

259 amining the brain basis of attention deficit hyperactivity disorder have not distinguished between pa

260 2.02 [95% CI, 1.80-2.26]; attention-deficit/hyperactivity disorder HR, 2.21 [95% CI, 2.04-2.39]).

261 3.45; 95% CI, 1.62-7.33), attention-deficit/hyperactivity disorder (HR = 13.13; 95% CI, 6.85-25.16),

262 3 [95% CI, 0.62-1.13]), or attention-deficit/hyperactivity disorder (HR, 0.99 [95% CI, 0.79-1.25]).

263 ed as having or not having attention deficit hyperactivity disorder in childhood and again in adultho

264 schizophrenia, autism, and attention-deficit/hyperactivity disorder in humans.

265 tism spectrum disorder and attention-deficit/hyperactivity disorder in offspring.

266 most common diagnoses were attention-deficit/hyperactivity disorder in younger children (52.5%), olde

267 nd effective treatment for attention-deficit/hyperactivity disorder, in healthy adults.

268 the contemporary debate on attention deficit hyperactivity disorder, in which concerns about medicali

269 Attention-deficit/hyperactivity disorder is associated with an increased r

270 Attention-deficit/hyperactivity disorder is associated with an increased r

271 Attention-deficit/hyperactivity disorder is often treated with medication,

272 exposure early in life and attention deficit hyperactivity disorder, language processing, and cogniti

273 sistence and remittance of attention deficit hyperactivity disorder may provide a framework for the r

274 atric illnesses, including attention deficit hyperactivity disorder, mood disorders, and substance us

275 participants who never had attention deficit hyperactivity disorder (n = 17).

276 =3540), autism (N=16 146), attention-deficit/hyperactivity disorder (N=18 726) and affective disorder

277 a first-line treatment for attention deficit hyperactivity disorder, on D2/3 receptor availability in

278 mitter dysregulation, e.g. attention deficit hyperactivity disorder or Alzheimer's disease.

279 association with comorbid attention-deficit/hyperactivity disorder or IQ, age range was associated w

280 Individuals with attention-deficit/hyperactivity disorder (probands) had increased risks of

281 : 1.4, 7.7) higher odds of attention deficit/hyperactivity disorder problems compared with children w

282 Psychiatric (autism, attention-deficit/hyperactivity disorder, psychosis, bipolar disorder, sui

283 ssociated with addiction, attention-deficit/ hyperactivity disorder, schizophrenia, and Parkinson's d

284 ectual disability, autism, attention-deficit/hyperactivity disorder, schizophrenia, bipolar disorder,

285 ture of DD overlapped with attention-deficit/hyperactivity disorder, schizophrenia, major depression,

286 autism spectrum disorders, attention deficit/hyperactivity disorder, severe learning disability, cere

287 bipolar disorder, autism, attention-deficit/hyperactivity disorder, suicide attempts, substance use,

288 ain Outcomes and Measures: Attention-deficit/hyperactivity disorder symptom trajectories from ages 4

289 itude) relates to specific attention-deficit/hyperactivity disorder symptoms (hyperactivity, but not

290 vioral problems, including attention-deficit/hyperactivity disorder symptoms and conduct disorder pro

291 ild executive function and attention-deficit/hyperactivity disorder symptoms) and confounders (child

292 o slower processing speed, attention-deficit/hyperactivity disorder symptoms, and externalizing probl

293 dopaminergic mechanisms of attention deficit/hyperactivity disorder that extends into the healthy pop

294 ior among individuals with attention-deficit/hyperactivity disorder, the development of more effectiv

295 ified 51 707 patients with attention-deficit/hyperactivity disorder (through patient and prescribed d

296 We show medicalisation in attention deficit hyperactivity disorder to be a complex issue that requir

297 Attention-deficit/hyperactivity disorder was not significantly related to

298 The odds of having attention deficit hyperactivity disorder was significantly increased in ch

299 01) with schizophrenia and attention deficit hyperactivity disorder were also nominally associated wi

300 aturation and diagnosis of attention-deficit/hyperactivity disorder were identified.